Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORONA PET Sub-Study
NCT00228514Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin in chronic heart failure (CHF), sponsored by AstraZeneca. Started Feb 2004; status: completed.
02
Drugs
rosuvastatin
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT00228514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228514.